Merck KGaA : Incorporating higher estimates for Healthcare and Electronics
>Second quarter with strong quarter for Healthcare and Electronics - Merck had already reported, on 26 July, preliminary Q2 results ahead of expectations with revenues of € 5,352m (+0.9% y-o-y). On the bottom line, the company reported EBITDA pre of € 1,509m (-2.9% y-o-y, margin 28.2%). EPS pre reached € 2.20. The company now expects revenues in the range of € 20.7bn to € 22.1bn (previously € 20.6bn to € 22.1bn), which compares to our new forecast of € 21.4bn. On EBIT...Merck is a global science and technology company based in Germany. Co. diversifies its activities into four business divisions: Merck Serono, Consumer Health, Performance Materials and Merck Millipore. The Merck Serono develops, manufactures and markets prescription drugs to treat cancer, multiple sclerosis, infertility, growth disorders, and selected cardiovascular and metabolic diseases. The Consumer Health manufactures and markets over-the-counter drugs addressing health themes such as mobility, women's and children's health, cough and cold. Performance Materials is a specialty chemicals business. The Merck Millipore is the supplier of products and services for the life science industry.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.